Log in

LON:MRLMarlowe Share Price, Forecast & News

GBX 530
+17.00 (+3.31 %)
(As of 07/7/2020 04:25 AM ET)
Today's Range
Now: GBX 530
50-Day Range
MA: GBX 488.37
52-Week Range
Now: GBX 530
Volume183,687 shs
Average Volume17,193 shs
Market Capitalization£244.04 million
P/E Ratio320.63
Dividend YieldN/A
Marlowe plc provides fire and security, water treatment, and air hygiene services in the United Kingdom. It operates through two segments, Fire Protection & Security Systems, and Water Treatment & Air Quality. The company designs, installs, and maintains fire protection and security systems for retailers, banks, and housing associations, as well as leisure, education, retail, local authority customers; and provides integrated water treatment, hygiene, testing, and engineering services. It is also involved in the installation and maintenance of fire suppression systems; and provision of ventilation maintenance, ductwork cleaning and management, kitchen extract cleaning, and contamination remediation services to national hotel and leisure providers, airports, NHS trusts, universities, local authorities, and FTSE Companies. The company was formerly known as Marlowe Holdings Limited. Marlowe plc was incorporated in 2006 and is based in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.88 out of 5 stars

Industry, Sector and Symbol

Industry Security & Protection Services



Sales & Book Value

Annual Sales£161.40 million
Cash FlowGBX 15.97 per share
Book ValueGBX 211.10 per share



Market Cap£244.04 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MRL News and Ratings via Email

Sign-up to receive the latest news and ratings for MRL and its competitors with MarketBeat's FREE daily newsletter.

Marlowe (LON:MRL) Frequently Asked Questions

How has Marlowe's stock been impacted by COVID-19 (Coronavirus)?

Marlowe's stock was trading at GBX 436 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MRL stock has increased by 21.6% and is now trading at GBX 530. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Marlowe?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Marlowe in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Marlowe.

What price target have analysts set for MRL?

1 analysts have issued 12-month price targets for Marlowe's shares. Their forecasts range from GBX 540 to GBX 540. On average, they expect Marlowe's share price to reach GBX 540 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price. View analysts' price targets for Marlowe.

Has Marlowe been receiving favorable news coverage?

News coverage about MRL stock has trended negative on Tuesday, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Marlowe earned a news impact score of -2.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Marlowe.

Who are some of Marlowe's key competitors?

Who are Marlowe's key executives?

Marlowe's management team includes the following people:
  • Mr. Alex Dacre, CEO & Director
  • Mr. Mark Andrew Adams, Group Fin. Director & Director (Age 54)
  • Mr. Robert Flinn, Chief Exec. of Fire & Security Division (Age 47)
  • Matthew Allen, Company Sec.

What is Marlowe's stock symbol?

Marlowe trades on the London Stock Exchange (LON) under the ticker symbol "MRL."

How do I buy shares of Marlowe?

Shares of MRL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Marlowe's stock price today?

One share of MRL stock can currently be purchased for approximately GBX 530.

How big of a company is Marlowe?

Marlowe has a market capitalization of £244.04 million and generates £161.40 million in revenue each year. Marlowe employs 1,700 workers across the globe.

What is Marlowe's official website?

The official website for Marlowe is www.marloweplc.com.

How can I contact Marlowe?

Marlowe's mailing address is 20 Grosvenor Place, LONDON, SW1X 7HN, United Kingdom. The company can be reached via phone at +44-20-38138498.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.